Anti-dementia drugs

✍ Scribed by Harry Allen

• Publisher: John Wiley and Sons
• Year: 1999
• Tongue: English
• Weight: 76 KB
• Volume: 14
• Category: Article
• ISSN: 0885-6230
• DOI: 10.1002/(sici)1099-1166(199904)14:4<239::aid-gps918>3.0.co;2-7

✦ Synopsis

New Drugs for Dementia

The introduction of new drugs for dementia has posed a number of problems for clinicians and prescribers with regard to their ecacy and how best they should be introduced into practice. The ®rst ®ve contributions of this issue bring together a number of dierent perspectives. Dr Allen starts with an overview of the new agents; Drs Swanwick and Lawlor describe issues about implementing a protocol for the treatment of the disease; a review of such protocols in the UK is provided by Dr Harvey; Dr Johnson comments from the point of view of a medical director of a health authority, the body ultimately responsible for the provision of health services within a de®ned area in the UK, on the very dicult concerns surrounding the introduction of a new age drug; and Dr Graham and colleagues comment on the reasons for clinical involvement in drug trials.